The Russell 2000 Index has soared, but you -2-
Omega Therapeutics Inc. OMGA 100% $3.01 $12.00 299% Allogene Therapeutics Inc. ALLO 82% $3.21 $12.79 298% X4 Pharmaceuticals Inc. XFOR 86% $0.84 $3.26 289% Caribou Biosciences Inc. CRBU 89% $5.73 $22.25 288% Stoke Therapeutics Inc. STOK 78% $5.26 $19.33 268% Source: FactSet
That's right - this Russell 2000 list is all biotech. And in case you are wondering if any companies are on both lists, the answer is now.
Don't miss: 11 dividend stocks with high yields expected to be well supported in 2024 per strict criteria
-Philip van Doorn
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-02-24 1226ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks